Cardiac Ablation Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
Report ID: GMI3702
Cardiac Ablation Market size is projected to experience significant growth from 2019 to 2025.
Increasing patient pool suffering from cardiac arrest, atrial fibrillation and other cardiovascular diseases (CVD) will impel cardiac ablation market growth in upcoming period. The patient mortality rate due to heart arrest will escalate the need for cardiac ablation. High success rate of cardiac ablation will further support rise in demand. For instance, in 2015, about 357,000 patients in U.S. suffered out-of-hospital cardiac arrest. Such upward trend in CVDs will accelerate cardiac ablation industry growth in recent years.
Rising demand for minimally invasive (MI) procedures will augment business growth over the forthcoming period. Minimally invasive procedures result in minimal blood loss and pain. For instance, video-assisted minimally invasive ablation has high success rates of surgeries and are effective and safe. Aforementioned benefits should increase the customer preference for MI cardiac ablation.
Technological advancements in cardiac ablation devices will accelerate the business growth in upcoming period. According to a recent clinical data, technology advancements in cardiac ablation lowers repeat procedures by about 33% along with decreased complications. The radiofrequency ablation technology has become a standard technology due to such advantages. Thus, advancements and innovations in cardiac ablation technology will render attractive business growth opportunities.
However, risk of infection from catheters and stringent regulatory approval procedure may hamper market growth over forecast timeframe.
Radiofrequency ablators product segment will show lucrative growth during the forecast timeframe. High segmental growth is attributed to high success rate of procedures. Rising number of cardiovascular devices such as sinus tachycardia, atrial fibrillation and arrhythmia should further spur the demand for radiofrequency ablators. Moreover, improved survival rate and higher effectivity will further boost segmental growth in recent years.
Cardiac rhythm management application segment will grow at robust rate during the projected timeframe. Increasing incidence of atrial fibrillation in geriatric population should assist business growth. In addition, changing lifestyle such as smoking, alcoholism, poor eating habits increases the risk of suffering from CVDs that will in turn propel segmental revenue share.
U.S. cardiac ablation market should witness robust growth owing to rising number of patients affecting from cardiac diseases. For instance, approximately 519,951 inpatient ablation procedures were conducted in the U.S. between 2000 and 2013 and a positive trend is estimated to be followed over the forecast period. Access to technologically advanced products in the country will further contribute to growing adoption of cardiac ablation in upcoming years.
Indian cardiac ablation market will show remarkable growth in foreseeable future. Huge population base suffering from CVD owing to sedentary lifestyles, changing habits and adoption of binge eating habits is positively contributing to market growth. Expanding healthcare infrastructure and facilities should further augment cardiac ablation market growth in the country over the coming years.
Prominent industry players involved in global cardiac ablation market include Alcon Laboratories, Boston Scientific Corporation, Johnson & Johnson, Medtronic, and St. Jude Medical. Firms are introducing novel technology and strategic alliances to strengthen their market footprint. For instance, in August 2015, BioSense Webster (Johnson & Johnson) introduced ThermoCool SmartTouch SF catheter in the U.S. This launch will fortify company’s product base and enhance its geographical reach.
Cardiac Ablation Market By Product, 2014-2025 (USD Million)
- Radiofrequency (RF) Ablators
- Electrical Ablators
- Cryoablation Devices
- Ultrasound Ablators
- Ultrasound Ablation Systems
Cardiac Ablation Market By Application, 2014-2025 (USD Million)
- Cardiac Rhythm Management
- Cardiac Arrhythmia
- Atrial Fibrillation and Flutter
- Open Surgery
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Advanced Cardiac Therapeutics
- Alcon Laboratories
- Biosense Webster (Johnson & Johnson.)
- Boston Scientific Corporation
- Conmed Corporation
- Olympus Corporation
- St. Jude Medical
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability